Qinglan Guo1, Adam D Tomich2, Christi L McElheny2, Vaughn S Cooper3, Nicole Stoesser4, Minggui Wang5, Nicolas Sluis-Cremer2, Yohei Doi6. 1. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China. 2. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 3. Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 4. Modernizing Medical Microbiology Consortium, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 5. Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China Key Laboratory of Clinical Pharmacology of Antibiotics, Ministry of Health, Shanghai, China. 6. Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA yod4@pitt.edu.
Abstract
OBJECTIVES: The objectives of this study were to elucidate the genetic context of a novel plasmid-mediated fosA variant, fosA6, conferring fosfomycin resistance and to characterize the kinetic properties of FosA6. METHODS: The genome of fosfomycin-resistant Escherichia coli strain YD786 was sequenced. Homologues of FosA6 were identified through BLAST searches. FosA6 and FosA(ST258) were purified and characterized using a steady-state kinetic approach. Inhibition of FosA activity was examined with sodium phosphonoformate. RESULTS: Plasmid-encoded glutathione-S-transferase (GST) FosA6 conferring high-level fosfomycin resistance was identified in a CTX-M-2-producing E. coli clinical strain at a US hospital. fosA6 was carried on a self-conjugative, 69 kb IncFII plasmid. The ΔlysR-fosA6-ΔyjiR_1 fragment, located between IS10R and ΔIS26, was nearly identical to those on the chromosomes of some Klebsiella pneumoniae strains (MGH78578, PMK1 and KPPR1). FosA6 shared >99% identity with chromosomally encoded FosA(PMK1) in K. pneumoniae of various STs and 98% identity with FosA(ST258), which is commonly found in K. pneumoniae clonal complex (CC) 258 including ST258. FosA6 and FosA(ST258) demonstrated robust GST activities that were comparable to each other. Sodium phosphonoformate, a GST inhibitor, reduced the fosfomycin MICs by 6- to 24-fold for K. pneumoniae and E. coli strains carrying fosA genes on the chromosomes and plasmids, respectively. CONCLUSIONS: fosA6, probably captured from the chromosome of K. pneumoniae, conferred high-level fosfomycin resistance in E. coli. FosA6 functioned as a GST and inactivated fosfomycin efficiently. K. pneumoniae may serve as a reservoir of fosfomycin resistance for E. coli.
OBJECTIVES: The objectives of this study were to elucidate the genetic context of a novel plasmid-mediated fosA variant, fosA6, conferring fosfomycin resistance and to characterize the kinetic properties of FosA6. METHODS: The genome of fosfomycin-resistant Escherichia coli strain YD786 was sequenced. Homologues of FosA6 were identified through BLAST searches. FosA6 and FosA(ST258) were purified and characterized using a steady-state kinetic approach. Inhibition of FosA activity was examined with sodium phosphonoformate. RESULTS: Plasmid-encoded glutathione-S-transferase (GST) FosA6 conferring high-level fosfomycin resistance was identified in a CTX-M-2-producing E. coli clinical strain at a US hospital. fosA6 was carried on a self-conjugative, 69 kb IncFII plasmid. The ΔlysR-fosA6-ΔyjiR_1 fragment, located between IS10R and ΔIS26, was nearly identical to those on the chromosomes of some Klebsiella pneumoniae strains (MGH78578, PMK1 and KPPR1). FosA6 shared >99% identity with chromosomally encoded FosA(PMK1) in K. pneumoniae of various STs and 98% identity with FosA(ST258), which is commonly found in K. pneumoniae clonal complex (CC) 258 including ST258. FosA6 and FosA(ST258) demonstrated robust GST activities that were comparable to each other. Sodium phosphonoformate, a GST inhibitor, reduced the fosfomycin MICs by 6- to 24-fold for K. pneumoniae and E. coli strains carrying fosA genes on the chromosomes and plasmids, respectively. CONCLUSIONS: fosA6, probably captured from the chromosome of K. pneumoniae, conferred high-level fosfomycin resistance in E. coli. FosA6 functioned as a GST and inactivated fosfomycin efficiently. K. pneumoniae may serve as a reservoir of fosfomycin resistance for E. coli.
Authors: James A Karlowsky; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Heather J Adam; Melanie R Baxter; Daryl J Hoban; George G Zhanel Journal: Antimicrob Agents Chemother Date: 2013-12-09 Impact factor: 5.191
Authors: Andrea Endimiani; Gopi Patel; Kristine M Hujer; Mahesh Swaminathan; Federico Perez; Louis B Rice; Michael R Jacobs; Robert A Bonomo Journal: Antimicrob Agents Chemother Date: 2009-11-09 Impact factor: 5.191
Authors: Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper Journal: Clin Infect Dis Date: 2011-03-01 Impact factor: 9.079
Authors: Rachel E Rigsby; Chris L Rife; Kerry L Fillgrove; Marcia E Newcomer; Richard N Armstrong Journal: Biochemistry Date: 2004-11-02 Impact factor: 3.162
Authors: James R Johnson; Sarah M Drawz; Stephen Porter; Michael A Kuskowski Journal: Antimicrob Agents Chemother Date: 2013-07-22 Impact factor: 5.191
Authors: Hanna E Sidjabat; David L Paterson; Jennifer M Adams-Haduch; Lindsay Ewan; Anthony W Pasculle; Carlene A Muto; Guo-Bao Tian; Yohei Doi Journal: Antimicrob Agents Chemother Date: 2009-08-17 Impact factor: 5.191
Authors: Kieran A Milner; Denice C Bay; David Alexander; Andrew Walkty; James A Karlowsky; Michael R Mulvey; Meenu K Sharma; George G Zhanel Journal: Antimicrob Agents Chemother Date: 2020-12-16 Impact factor: 5.191
Authors: Erik H Klontz; Adam D Tomich; Sebastian Günther; Justin A Lemkul; Daniel Deredge; Zach Silverstein; JoAnna F Shaw; Christi McElheny; Yohei Doi; Patrick L Wintrode; Alexander D MacKerell; Nicolas Sluis-Cremer; Eric J Sundberg Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191
Authors: Aaron E Lucas; Ryota Ito; Mustapha M Mustapha; Christi L McElheny; Roberta T Mettus; Sarah L Bowler; Serena F Kantz; Marissa P Pacey; A William Pasculle; Vaughn S Cooper; Yohei Doi Journal: J Clin Microbiol Date: 2017-12-26 Impact factor: 5.948
Authors: Ryota Ito; Adam D Tomich; Christi L McElheny; Roberta T Mettus; Nicolas Sluis-Cremer; Yohei Doi Journal: Antimicrob Agents Chemother Date: 2017-11-22 Impact factor: 5.191
Authors: Ryota Ito; Marissa P Pacey; Roberta T Mettus; Nicolas Sluis-Cremer; Yohei Doi Journal: J Antimicrob Chemother Date: 2018-02-01 Impact factor: 5.790